IFLR1000

Catherine Chen

Zhong Lun Law Firm - China
Select tab

Partner

Shanghai

+86 21 6061 3599

Contact this lawyer

Visit website

Highly regarded

Chinese & English

Bar admissions:

China

Jurisdictions:

China

Practice areas:

Investment funds

Recent transactional highlights

  • Advised Curon Biopharmaceutical on its US$150 million Series A financing, led by 6 Dimensions, Temasek and Boyu
  • Advised IDG on the formation of semiconductor and AI merger fund (Yiwu Jinhong Fund). This fund has raised RMB10.8 billion and is still in the process of fundraising.
  • Advised client during the whole process of the formation of the Beijing Fund (the “Fund”) jointly established by Tishman Speyer and Shougang Fund. Matter value is about RMB1.8 billion
  • Advised Lilly Asia Ventures on the merger of its portpolios, Hangzhou Just Biotherapeutics and MabSpace Biosciences to create Transcenta Holding Ltd., a world-class biotherapeutics company.

Practice areas

  • Investment funds
  • Private equity

Sector specialisations

  • Financial services
  • Healthcare
  • Investment management
  • Pharma and life sciences

Bar admissions

  • PRC Admitted Lawyer

Association memberships

  • Secretary General, CEIBS Alumni PE Association Shanghai 
  • Member, Shanghai Bar Association Fund Research Committee 
  • Mediator, Shanghai Pudong Professional Mediation Center 
  • Co-chair, Fund Asset Backed Securitization Committee of China Asset Backed Securitization Forum

Academic qualifications

  • LL.M. (East China Univ. of Political Science and Law) 
  • LL.B. (East China Univ. of Political Science and Law)
  • EMBA (China Europe International Business School)

Related lawyers

Jason Liu

Partner

Zhong Lun Law Firm

Anthony Zhao

Partner

Zhong Lun Law Firm

Chen Limin

Partner

Zhong Lun Law Firm

Dongyue Chen

Partner

Zhong Lun Law Firm

Hao Dong

Partner

Zhong Lun Law Firm
View all